Home
Conditions
Muscular Atrophy, Spinal

Clinical trial condition

Muscular Atrophy, Spinal

Explore clinical trials studying Muscular Atrophy, Spinal. Study availability and eligibility vary by location and protocol.

56 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Muscular Atrophy, Spinal trial results

Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT01793168

Conditions: 1p36 Deletion Syndrome, 3-Methylglutaconic Aciduria, Type V, 4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome, +698 more
Locations: Sanford Health Sioux Falls, South Dakota, United States

Online Patient Enrollment System Sydney, Australia

View Trial Details

Recruiting

Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy

NCT06862596

Conditions: Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Tokyo University Hospital Bunkyō City, Japan

Chiba University Hospital Chiba, Japan

Hokkaido University Hospital Sapporo, Japan

Jichi Medical University Hospital Shimotsuke, Japan

View Trial Details

Recruiting

A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy

NCT06169046

Conditions: Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Azienda Ospedale Università di Padova Padova, PD, Italy

View Trial Details

Not yet recruiting

Exploring Lived Experiences of Families of Children With Spinal Muscular Atrophy(SMA) Type 1 Regarding Feeding and Communication

NCT07596277

Conditions: Behavior, Central Nervous System Diseases, Communication, +20 more
Locations: GSTT Evelina Neurosciences London, United Kingdom

View Trial Details

Enrolling by invitation

GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy

NCT06772402

Conditions: Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations: Children's Hospital ZheJiang Univisity School Of Medicine Hangzhou, Zhejiang, China

View Trial Details

Enrolling by invitation

Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1

NCT05614531

Conditions: Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations: The Children's Hospital of Fudan University Shanghai, Shanghai Municipality, China

The Children'S Hospital Zhejiang University of Medicine Hangzhou, Zhejiang, China

View Trial Details

Active, not recruiting

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

NCT04042025

Conditions: Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +12 more
Locations: Stanford University Medical Center Palo Alto, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Ann Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

John Hopkins Hospital - David M. Rubenstein Child Health Building Baltimore, Maryland, United States

View all 31 locations

View Trial Details

Active, not recruiting

Long-Term Follow-up Study for Patients From AVXS-101-CL-101

NCT03421977

Conditions: Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Active, not recruiting

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

NCT06764485

Conditions: Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations: Local Institution - 0370 Anaheim, California, United States

Local Institution - 0077 Athens, Georgia, United States

Local Institution - 0085 New York, United States

Local Institution - 0056 Columbus, Ohio, United States

View all 212 locations

View Trial Details

Active, not recruiting

pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

NCT04090528

Conditions: Bulbo-Spinal Atrophy, X-Linked, Castration-resistant Prostate Cancer, Central Nervous System Diseases, +26 more
Locations: Washington University Siteman Cancer Center St Louis, Missouri, United States

University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Muscular Atrophy, Spinal

Muscular Atrophy, Spinal trial results

Related conditions